"&#xa0;\n&#xa0;\nWritten evidence from Roche Diagnostics UK (PEX 0011)&#xa0;Summary&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;Diabetes&#xa0;&#xa0;\n&#xa0;\n&#xa0;\nSelf-monitoring of blood glucose (SMBG) &#xa0;&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\nDiabetes self-monitoring restrictions&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\nAccess to innovative blood glucose testing&#xa0;\n&#xa0;Conclusion&#xa0;\n&#xa0;\n&#xa0;\nAbout Roche Diagnostics UK &#xa0;\n&#xa0;\n&#xa0;\nNovember 2013\n&#xa0;\n State of the Nation 2012: England, Diabetes UK\n \nSelf-monitoring of \nblood glucose levels f\nor adults with Type 2 diabetes, April 2013, Diabetes UK\n \nCardiovascular - type 2 diabetes. Data focused commentary: Type 2 diabetes: Self-monitoring blood glucose. Nat\nional Prescribing Centre (2012)\n \nhttps://www.gov.uk/government/uploads/system/uploads/attachment_data/file/156336/Safe-care-of-people-with-type-1-diabetes.pdf.pdf\n (accessed 01\n November\n 2013)\n \nACCESS TO TEST STRIPS: A POSTCODE LOTTERY? \nSelf-monitoring\n of blood glucose by people with Type 1 and Type 2 diabetes, August 2013, Diabetes UK\n"